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background: Little is known about the relationship between renal function and outcomes of endovascular therapy (EVT) for femoropopliteal lesion.
methods: REAL-FP is a retrospective multicenter analysis of EVT for femoropopliteal lesions at 13 Japanese medical centers from January 2004 
to December 2011. 2742 patients, 3471 limbs were registered and we analyzed the relationship between renal function and EVT outcomes. The 
renal function was estimated by the equation which Japanese society of nephrology has advocated, and classified as follows. Chronic kidney disease 
(CKD) stage G1: Glomerular filtration rate (GFR) (ml/min/1.73m2) > 90, G2:60 to 89, G3a:45 to 59, G3b:30 to 44, G4:15 to 29, G5:<15 (add D if 
treated by dialysis). The outcome measures were primary patency, secondary patency and amputation free survival.
results: The mean follow interval was 775 ± 606 days. Mean age was 73 years old, 69% was male. Number of each CKD stages was as follows: 
stage G1 91, G2 604, G3a 455, G3b 309, G4 156, G5 29, and G5D 610. At 2 years, compared to stage G1 ,G2 ,G3a ,G3b ,G4 and G5, stage 
G5D had worse cumulative primary patency (65.0%±5.1%, 65.1%±2.0%, 68.6%±2.2%, 67.2%±2.8%, 66.9%±4.1%, 79.6%±8.3%, 56.7%±2.2%, 
respectively, log-rank p<0.0001). However, there were not significant differences among stage G1, G2, G3a, G3b, G4 and G5. In secondary patency, 
there were no significant differences among CKD stages. In amputation free survival, compared to other CKD stages, stage 5D had worse cumulative 
amputation free survival (93.9%±2.5%, 93.0%±1.1%, 92.2%±1.3%, 90.0%±1.8%, 80.3%±3.5%, 92.7%±5.0%, 73.3%±1.8%, respectively, p<0.0001). 
Mortality contributed to this result greatly. After adjustment, hemodialysis was still independent predictors of primary patency and amputation free 
survival.
conclusions: When it comes to the relationship between renal function and EVT outcomes, our study suggests only CKD stage G5D was related to 
EVT outcomes. There were no significant differences among stage G1, G2, G3a, G3b, G4 and G5 in outcomes of EVT for femoropopliteal lesion.
